Director/PDMR Shareholding

RNS Number : 1838Q
Hikma Pharmaceuticals Plc
04 June 2018
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge by Darhold Limited over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc.  The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.76%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,800,000

d)

Aggregated information

Aggregated volume: 1,800,000

Price: £0.00p

e)

Date of the transaction

4 June 2018

f)

Place of the transaction

Amman

 Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge by Darhold Limited over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc.  The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.96%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,800,000

d)

Aggregated information

Aggregated volume: 1,800,000

Price: £0.00p

e)

Date of the transaction

4 June 2018

f)

Place of the transaction

Amman

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Release of a pledge by Darhold Limited over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc.  The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.05%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,800,000

d)

Aggregated information

Aggregated volume: 1,800,000

Price: £0.00p

e)

Date of the transaction

4 June 2018

f)

Place of the transaction

Amman

Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGCGDLRDGBGIS
UK 100

Latest directors dealings